Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Streptococcal Adhesin P (SadP) contributes to Streptococcus suis adhesion to the human intestinal epithelium

  • Maria Laura Ferrando ,

    m.l.ferrando@amc.uva.nl

    Affiliations Department of Medical Microbiology, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Global Health-Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  • Niels Willemse,

    Affiliations Department of Medical Microbiology, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Global Health-Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  • Edoardo Zaccaria,

    Affiliation Host-Microbe Interactomics, Animal Sciences, Wageningen University, Wageningen, The Netherlands

  • Yvonne Pannekoek,

    Affiliation Department of Medical Microbiology, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  • Arie van der Ende,

    Affiliation Department of Medical Microbiology, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  • Constance Schultsz

    Affiliations Department of Medical Microbiology, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Global Health-Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Abstract

Background

Streptococcus suis is a zoonotic pathogen, causing meningitis and septicemia. We previously demonstrated that the gastrointestinal tract (GIT) is an entry site for zoonotic S. suis infection. Here we studied the contribution of Streptococcal adhesin Protein (SadP) to host-pathogen interaction at GIT level.

Methods

SadP expression in presence of Intestinal Epithelial Cells (IEC) was compared with expression of other virulence factors by measuring transcript levels using quantitative Real Time PCR (qRT-PCR). SadP variants were identified by phylogenetic analysis of complete DNA sequences. The interaction of SadP knockout and complementation mutants with IEC was tested in vitro.

Results

Expression of sadP was significantly increased in presence of IEC. Sequence analysis of 116 invasive strains revealed five SadP sequence variants, correlating with genotype. SadP1, present in zoonotic isolates of clonal complex 1, contributed to binding to both human and porcine IEC and translocation across human IEC. Antibodies against the globotriaosylceramide Gb3/CD77 receptor significantly inhibited adhesion to human IEC.

Conclusion

SadP is involved in the host-pathogen interaction in the GIT. Differences between SadP variants may determine different affinities to the Gb3/CD77 host-receptor, contributing to variation in adhesion capacity to host IEC and thus to S. suis zoonotic potential.

Introduction

Streptococcus suis (SS) is an emerging zoonotic pathogen which can cause severe disease including meningitis and septic shock in human and pigs [1]. The capsular polysaccharide (CPS) is a virulence factor of S. suis which determines the serotype; the virulence and prevalence differ within and among serotypes [2]. In addition to serotype, the genotype contributes to virulence of S. suis [3, 4]. Invasive S. suis strains are limited to certain sequence types (ST), as determined by multi locus sequence typing (MLST). S. suis serotype 2 (SS2) isolates belonging to MLST clonal complex 1 (SS2/CC1) are considered highly virulent and zoonotic [2]. In the Netherlands, SS2 isolates belonging to MLST clonal complex 20 (SS2/CC20), also contribute to human disease [4]. In contrast, S. suis serotype 9 (SS9), part of MLST clonal complex 16 (SS9/CC16) and the main cause of porcine S. suis infections in Northern Europe, is rarely associated with human infection [4, 5]. Therefore, CC1, CC16 and CC20 are most common virulent genotypes circulating in the Netherlands.

Epidemiological and experimental studies indicated that SS2/CC1 infection is a foodborne disease in Southeast Asia in adult patients caused by the consumption of contaminated undercooked pork [69]. So far, it still unknown which bacterial factors contribute to potential risk of S. suis zoonotic transmission through the S. suis translocation of the human gastrointestinal tract.

We previously demonstrated that SS2/CC1 adhered to and translocated across intestinal epithelial cells (IEC) of both human and porcine origin in vitro, and translocated the gastrointestinal tract (GIT) in a piglet model after S. suis oral infection [6]. The capacity of S. suis isolates to adhere to human and porcine IEC correlated with serotype as SS9 isolates showed significantly less binding to human IEC than SS2 isolates, suggesting that CPS composition and structure mediate host species restriction. In addition, whilst the CPS was shown to prevent adhesion to host-cells in in vitro models [6, 10], unencapsulated cps mutant strains of serotype 2 and 9 appeared to retain the host restriction of their encapsulated parental strains when interacting with human and porcine IEC [6]. Thus, in addition to the capsule, secreted or cell-associated virulence factors such as adhesins are likely to contribute to host-specific interactions of S. suis with IEC.

Streptococcal adhesin P (SadP) is a cell-wall adhesin which can recognize galactosyl-α1-4galactose (Galα1-4Gal or galabiose) [11] present as the terminal epitope of globoseries glycolipids (Gbs) receptors on erythrocytes [12]. Analysis of SadP binding specificity to galabiose present in the Gbs receptors revealed the highest specificity to the globotriaosylceramide Gb3/CD77 receptor [11]. Gb3/CD77 receptors are abundant in various host tissues including human and pig small intestine in the precursor (Gb3/CD77) or mature form (globotetraosylceramide Gb4) [13, 14]. Furthermore, Gb3/CD77 is a receptor for adhesin-mediated binding to host tissues of multiple human pathogens and serves as receptor for bacterial toxins (Shiga toxins, Stx) [15].

First, we determined the relevance of SadP in adhesion to intestinal epithelial cells in comparison to other well-characterized virulence-associated factors. Therefore, we assessed transcription levels in S. suis in the presence or absence of intestinal epithelial cells of well-characterized S. suis secreted or cell-associated factors selected on the basis of their functional role in bacterial interaction with the host epithelium [16]. The differential transcription of sadP was highest among eight virulence-associated factors. We hypothesized that SadP plays a dominant role in the interaction of S. suis with porcine and human intestinal epithelium, and we performed a comparative study of SadP mediated adherence of S. suis serotype 2 (belonging to CC1 and CC20) and 9 (belonging to CC16).

Materials and methods

Bacterial strains and intestinal cell lines

Bacterial isolates used are listed in Table A in S1 File. All strains were grown in Todd-Hewitt Broth with 5% Yeast (THY) or on Columbia blood agar plates (Difco). E. coli BHB2600 [17] was cultured in Luria-Bertani (LB) broth or on LB agar (Difco). When necessary, antibiotics were added to culture media at the following concentrations: for E. coli 50 mg/L spectinomycin (spc); for S. suis 200 mg/L kanamycin (kan) and 100 mg/L spc. Caco-2 cells (HTB-37™, ATCC) and IPEC-J2 cells (ACC 701, DSMZ) were grown as previously described [18, 19].

RNA extraction from co-culture of S. suis and IECs

Caco-2 and IPEC-J2 cells were cultivated in triplicate in T25 flasks until differentiation [6]. Co-culture of IEC-bacteria was conducted without antibiotics and Fetal Calf Serum (FCS). The bacterial suspension (~ 50 bacteria/cell Multiplicity Of Infection [MOI]) was added to flasks with IEC and without IEC (control) and incubated for 4 hours at 37°C in 5% CO2. The co-culture of bacteria and IECs was stopped by adding ice-cold 95% ethanol/5% phenol, pelleted, and stored at -80°C [20]. Total RNA was extracted using the hot-phenol method [20] followed by RNA purification with miRNeasy Minikit (Qiagen). Purified RNA was treated with TURBO DNA-free™ (Life Technologies). Quantity and quality of the RNA were measured with NanoDrop 2000 (Thermo Scientific) and Bioanalyzer (Agilent technologies).

Quantitative real time PCR (qRT-PCR)

Reverse transcription of the RNA was performed with ThermoScript rt-PCR (Invitrogen). Relative gene expression was determined by qRT-PCR using SYBR Green (Roche) using two housekeeping genes (proS and gdh) as reference genes [21]. All samples were run in biological triplicates. Primers are listed in Table B in S1 File and data were analyzed with LinRegPCR [22].

MLST and whole genome sequencing

The genotype of the strains was previously determined by MLST [4]. DNA isolation, library preparation, sequencing, and assembly were previously described in detail [23]. Briefly, S. suis genomic DNA was extracted and fragmented by sonication [23]. Sequencing libraries were created using an in-house protocol and paired-end sequencing was performed on the Illumina MiSeq sequencing platform [23]. The reads were trimmed with CutAdapt and Sickle [24] and assembled with SPAdes 3.0 [25].

Phylogenetics

Whole genome sequences (WGS) of 116 S. suis isolates were mined for the presence of SadP using NCBI's BLAST. Protein SSU0253 from strain P1/7 was used as query SadP sequence against a protein database, generated using Prodigal [26] predicted protein sequences from the draft genomes. The e-value was set at 1e-5 and proteins with >50% identity over >50% of the alignment were identified as SadP proteins. The corresponding nucleotide sequences of the 111 strains that were shown to contain SadP were aligned at the protein level using MUSCLE [27], and a phylogenetic tree was constructed using PhyML [28] with 100 bootstraps. An extended phylogenic analysis included 375 additional publicly available WGS of S. suis strains from the UK and Vietnam [29]. Prodigal was used to predict coding sequences in this dataset.

Construction of S. suis sadP deletion mutants

Primers used for mutagenesis are listed in Table B in S1 File. sadP deletion was achieved by gene replacement with the Janus cassette [30] carrying a kan gene. PCR fragments containing the flanked region of sadP (~ 0.5 kb) and Janus cassette were digested with ApaI/BamHI or EcoRI/BamHI and then ligated. ΔsadP::Janus fragment was PCR amplified from the ligation using Phusion DNA Polymerase (Thermo Fisher) with external primers, and successively transformed into S. suis in presence of the competence-inducing peptide ComS13-21 as previously described [31]. Transformants were selected on Columbia agar plates with kanamycin. The insertional mutagenesis of ΔsadP::Janus was confirmed by PCR and sequencing.

Complementation of deletion mutants

The pMX1 vector [32] was used for the generation of complementation mutants in strain 10ΔsadP1 (Table A in S1 File). The plasmid was maintained into E. coli BHB2600 kindly provided by Dr. S.A.J. Zaat [17] and extracted using GeneJET Plasmid Midiprep (Thermo Fisher). The complete sadP1, sadP2A, and sadP2B genes were amplified from genomic DNA of respective S. suis strains (Table B in S1 File) and cloned into pMX1 via EcoRI/BamHI sites. After ligation, the plasmid was directly introduced into 10ΔsadP1 in presence of ComS13-21 to construct 10ΔsadP1CsadP1, 10ΔsadP1CsadP2A and 10ΔsadP1CsadP2B complemented mutants.

Adherence and translocation assays using IECs

Adhesion and translocation assays were performed as previously described [6]. For inhibition of bacterial adhesion assays, Caco-2 cells were pre-incubated with increasing concentrations of monoclonal anti-Gb3/CD77 (Biocompare) in medium containing FCS, for 1 hour at 37°C, after which bacteria were added to the cells. Buffer (PBS, 0.1% sodium azide, 0.2% BSA) without antibody was used as a control.

Statistical analysis

Prism 6.0 (GraphPad software, USA) was used to analyse the normalized qPCR fold-ratio to the control (no cells) by One-way ANOVA. Unpaired Student's t-test was performed to compare the percentage of adhesion to and translocation across IECs between 10ΔsadP1 mutant and its parental strain.

Results

SadP gene expression increases in the presence of human and porcine IEC

We first used qPCR expression profiling during host-pathogen protein interactions to identify whether sadP expression was upregulated in presence of human and porcine IEC as an indication of its importance in adhesion. Therefore, we compared sadP transcript levels in comparison with other well-characterized S. suis secreted or cell-associated factors selected on the basis of their functional role in bacterial interaction with the host epithelium [16] as described in Table 1 [11, 3340]. Transcript levels were determined in isolates representing zoonotic (SS2/CC1 strain 10) and non-zoonotic (SS9/CC16 strain 8067) S. suis types (Table A in S1 File), following 4 hours of co-culture in cell culture media without IEC (control) and with human (Caco-2) and porcine (IPEC-J2) IECs. Transcript levels of sadP in both S. suis strains ranged from 4.5 to 8.5-fold (p<0.001) higher than bacteria grown without IEC (Fig 1). Interestingly, in S. suis grown in the presence of IECs transcript levels of cps were also higher (2.5 to 3.0-fold p<0.05 and p<0.001 respectively) compared to S. suis grown without IECs. Sly toxin transcript levels were 1.6 to 3.5-fold higher (p<0.05) in both strains when in contact with human IEC only. In contrast, transcript levels of ssnA in SS9/CC16 in presence of IEC were 1.4 fold lower compared to control (p<0.001). Transcript levels of genes coding for the other virulence factors were not significantly altered compared to the control without cells except for transcript levels of the protease ddp IV involved in cell invasion process [16, 21], which was significantly upregulated in SS2/CC1 in presence of both IECs (~ 3.0-fold higher with Caco-2 p<0.05 and IPEC-J2 p<0.001). The high levels of sadP transcripts compared to other virulence factors, suggested an important role of SadP during S. suis-IEC interaction among zoonotic and non-zoonotic isolates.

thumbnail
Fig 1.

Normalized differential gene expression of eight virulence factor genes during the interaction of SS2/CC1 strain 10 and SS9/CC16 strain 8067 with A) human (Caco-2) and B) porcine (IPEC-J2) IECs. RNA was extracted from the adherent SS2/CC1 strain 10 and SS9/CC16 strain 8067 after 4 hour of co-incubation with IECs to quantify the expression level of known virulence genes by qRT-PCR. As a control experiment, gene expression was estimated in S. suis strains incubated under identical conditions without epithelial cells. The expression of each gene was normalized to that of the internal reference proS and gdh genes [19]. Relative expression levels were calculated as the expression of a gene divided by that in non-adherent S. suis at the end of the experiment (4h), which was arbitrarily defined as 1. Data presented are averages of three independent experiments, and error bars represent standard deviations. The significance of differences in the expression of the genes in non-adherent and adherent S. suis was determined by one-way ANOVA indicated as follows: (***, p < 0.001; **, p < 0.01; *, p < 0.05).

https://doi.org/10.1371/journal.pone.0175639.g001

thumbnail
Table 1. Selected virulence genes [16] for qRT-PCR gene expression analysis.

https://doi.org/10.1371/journal.pone.0175639.t001

Variation of SadP protein sequences correlate with S. suis genotype

To determine the contribution of SadP to the bacteria-IEC interaction, we investigated whether genetic variation of SadP occurred among zoonotic and non-zoonotic isolates with different serotypes and genotypes. We detected five genetic variants of SadP in 111 out of 116 strains covering CC1, CC13, CC16, CC20, and CC27/29. The clustering of the five genetic variants occurred independent of the serotype but according to their clonal complex (Fig 2). We designated the variants SadP1 (CC1), SadP2A (CC20), SadP2B (CC16), SadP3 (CC13) and SadP4 (CC27/29). An expanded search including an additional 375 strains from Vietnam and the UK [29] demonstrated that these five variants are likely to cover the vast majority (94%) of SadP variants present in S. suis (Fig A in S1 File). At the amino acid (AA) level, SadP1 shares a similarity of 79% and 77% with SadP2A and SadP2B respectively. SadP2A and SadP2B exhibit a 99% similarity in AA-sequence and differ by the absence of the LPXTG cell-anchor motif in SadP2B, which suggests SadP2B might be secreted instead of anchored to the cell wall (Fig 3A and Fig 3C). The partial crystal structure of the galabiose-binding domain of the SadP1 adhesin (from 139–323 AA) has recently been resolved (PDB: 5BOA) [41]. The predicted secondary structures of SadP2A and SadP2B possess fewer α-helices, compared to SadP1 (Fig 3B).

thumbnail
Fig 2. Sequence analysis of SadP of 111 invasive strains isolated from humans and pigs, revealed substantial variation across different serotypes and genotypes.

SadP protein sequences clustered according to S. suis MLST clonal complexes (CC) genotype. Variants of SadP were identified in 111 out of 116 strains covering CC1, CC13, CC16, CC20 and CC27/29. SadP1 was present in zoonotic CC1 strains and was consistently present across serotype 2 isolates, whilst SadP2A and Sad2B were found in the zoonotic CC20 and non-zoonotic CC16 strains, respectively. Colored blocks indicate to which clonal complex a strain belongs and the range of each of the SadP variants is indicated with brackets.

https://doi.org/10.1371/journal.pone.0175639.g002

thumbnail
Fig 3. Structural comparison of SadP proteins and their subdomains in different S. suis strains.

(A) Schematic diagram of the domain organization of SadP in the primary sequence. The N-terminal domain (residues 55–200) includes the galabiose-binding domain (the blue arrow indicates the recombinant protein (31–328) of the N-terminal domain derived from SadP1 that showed high-affinity binding to the terminal-epitope galabiose of the Gb3/CD77 host-cell receptor. The C-terminal domain (residues 418–472; red), which should have H-factor-binding property, contains a Repeat Domain (RD) rich in proline [34]. The blue box indicates the YSIRK-type signal peptide (residues 5–30), and the black box indicates the LPXTG motif (residues 524–528) present only in SadP1 and SadP2A. (B) Schematic secondary structure solved by crystal structure analysis of the N-terminal galabiose-binding domain of SadP1 (PDB: 5BOB from 139–323 AA) (α-helix in red, 3/10 α-helix in fuchsia, β-sheets in blue). The secondary structures of SadP2A and SadP2B were predicted according to the solved structure of SadP1 deposited in http://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId=5BOB. (C) Comparison of primary AA-sequences of SadP1, SadP2A and SadP2B variants and the consensus sequence density. Sequences highlighted correspond to the secreted signal sequence (yellow), and the first and second series of repeat domains RD1 (cyan) and RD2 (green). RD1 is only present in SadP1 whilst the gram-positive anchor LPXTG motif is present only in SadP1 and SadP2A (magenta). The degree of consensus sequence density is indicated in pink. The galabiose-binding domain (31–328 AA in grey) showed the most variable AA-sequence among the three different variants (SadP1 vs SadP2A 69.9%, SadP1 vs SadP2B 69.1%, SadP2A vs SadP2B 99.3%). In the galabiose-binding domain, the binding sites versus the Gal1-4βGal of Gb2, an analog of Gb3/CD77, are indicated in dark blue [37]. The C-terminal region included two series of Pro-rich (Proline) Repeats Domains (RD) of a maximum of 66 AA (RD1) and 54 AA sequence (RD2) length. The number and length of repeats located in the C-terminal domain also varied within SadPs variants; in particular, SadP1 possessed a higher number of RD (first series: RD1-RD1; second series: RD2-RD2-RD2) which explains the observed size variation across SadP variants.

https://doi.org/10.1371/journal.pone.0175639.g003

Different forms of SadP vary in their contributions to bacterial adhesion to IEC

Next, we evaluated the contribution of SadP variants to adhesion to human and porcine IEC. We focused on SadP1 and two subvariants of SadP2 (SadP2A and SadP2B) as these variants were present in the most common zoonotic SS2/CC1 (SadP1) and SS2/CC20 (SadP2A) and non-zoonotic SS9/CC16 (SadP2B) strains (Fig 2). We deleted sadP1 in SS2/CC1 strain 10 and its unencapsulated mutant 10Δcps2 (10ΔsadP1 and 10Δcps2ΔsadP1 respectively). Adhesion was expressed as the total number of IEC associated bacteria, including both adherent and intracellular bacteria, proportional to the total number of bacteria added to the IEC infection model, since we have previously shown that under the test conditions the number of invasive bacteria is very low (from 0.04% to 0.01% of the starting inocolum) and can be neglected [6]. 10ΔsadP1 showed a two-fold reduction in adhesion to Caco-2 as well as to IPEC-J2 cells compared to the parental strain indicating that SadP1 contributes to the adhesion to both human and porcine IEC (p<0.001, Fig 4). The double knockout 10Δcps2ΔsadP1 also showed a two-fold reduction in adhesion compared to parental 10Δcps2 strain (p<0.001, Fig 4). However, no significant reduction in adhesion was observed when we tested 10Δcps2ΔsadP1 in contact with IPEC-J2 cells. Finally, we created sadP knockouts in SS9/CC16 strain 8067 (8067ΔsadP2B) and SS2/CC20 strain 2001171 (2001171ΔsadP2A) to test the adhesion properties of SadP2A and SadP2B in their natural genetic background. Adhesion capacity of both 2001171ΔsadP2A and 8067ΔsadP2B was similar compared to their parental strains when brought into contact with Caco-2 cells. In contrast, 8067ΔsadP2B adhered significantly less (1.6-fold) to the IPEC-J2 cells than the parental strain 8067 WT (p<0.01) indicating that SadP2B in SS9/CC16 strain 8067 contributed to the adhesion to porcine IEC (Fig B in S1 File).

thumbnail
Fig 4. SadP1 contributes to the adhesion of human and porcine IEC.

Adhesion to human (Caco-2) and porcine (IPEC-J2) IEC of WT 10 strain of SS2/CC1 and unencapsulated 10Δcps2 mutant and their isogenic sadP mutants (10ΔsadP1 and 10Δcps2ΔsadP1 respectively). Adhesion was expressed as the total number of IEC associated bacteria, including both adherent and intracellular bacteria, proportional to the total number of bacteria added to the IEC infection model. Three independent experiments (i.e.: biological replicates) were performed in triplicate and the combined together. Unpaired Student's t-test was used to compare each ΔsadP1 mutants with its own parental strains (***, p< 0.001; **, p< 0.01; *, p< 0.05).

https://doi.org/10.1371/journal.pone.0175639.g004

Complementation of sadP1 gene function with different of genetic variants of sadP

Complementation mutants were subsequently created by sub-cloning variants of with three different sadP (sadP1, sadP2A and sadP2B) in the 10ΔsadP1 with SS2/CC1 background. Growth kinetics did not differ significantly between the wild-type (WT) strain, 10ΔsadP1 and complementation mutants, and transcripts of each sadP variant were detected by qPCR (data not shown). Adhesion to Caco-2 cells was increased by expression of any of the three sadP variants in 10ΔsadP1, although not to WT levels (Fig 5). Adhesion of 10ΔsadP1CsadP1 to Caco-2 cells was 1.2-fold higher than that of 10ΔsadP1 (p = 0.057), but adhesion to IPEC-J2 cells was similar to that of the knockout. However, adhesion to Caco-2 cells of 10ΔsadP1CsadP2A was 1.4-fold higher (p = 0.02) and 10ΔsadP1CsadP2B was 1.3-fold higher (p = 0.004) than that of 10ΔsadP1. Only 10ΔsadP1CsadP2A was able to restore adhesion to IPEC-J2 cells, which was 3-fold higher than that of the 10ΔsadP1 (p = 0.003) (Fig 5).

thumbnail
Fig 5. Adhesion of S. suis ΔsadP1 deletion mutants and ΔsadP1 mutants complemented with different sadP variants, to human and porcine IEC.

Influence of SadP variants on adhesion of strain 10 of SS2/CC1 genetic background to human (Caco-2) and porcine (IPEC-J2) cells. All strains carry either an empty pMX1 (WT) or with one of three SadP variants cloned into pMX1 carrying a spcr gene. Results were determined after 2h of co-incubation with IECs at 37°C. Three independent experiments were performed in triplicate or quadruplicate and the combined together. Unpaired Student's t-test was used to compare each 10ΔsadP1 mutant or complemented mutants with its own parental strain (***, p< 0.001; **, p< 0.01; *, p< 0.05).

https://doi.org/10.1371/journal.pone.0175639.g005

S. suis adhesion to human IEC is inhibited by anti-Gb3/CD77

To further investigate if adhesion is indeed mediated through binding of SadP1 to Gb3/CD77, we performed an inhibition assay with anti-Gb3/CD77. The inhibition of adhesion by strain 10Δcps2 was compared with the unencapsulated mutant lacking SadP1 function (10Δcps2ΔsadP1) since this mutant showed dramatically reduced adhesion (approx. 2.0-fold, p<0.001) compared to its parental unencapsulated strain (10Δcps2). The adhesion of 10Δcps2 to human IEC was inhibited by anti-Gb3/CD77 in a dose-dependent manner while no significant inhibition effect could be observed with the double mutant 10Δcps2ΔsadP1 (Fig 6).

thumbnail
Fig 6. SadP1 contributes to adhesion to human IEC by binding the Gb3/CD77 receptor.

Dose-dependent competitive inhibition of human IEC (Caco-2) cells by anti-Gb3/CD77 antibody for SS2/CC1 10Δcps2 and SS2/CC1 10Δcps2ΔsadP1. Unpaired Student's t-tests were used to test significant different adhesion percentages compared to the parental strains (***, p< 0.001; **, p< 0.01; *, p< 0.05).

https://doi.org/10.1371/journal.pone.0175639.g006

SadP1 is involved in S. suis translocation across human intestinal epithelial cells

To test whether SadP1 might have an effect on the translocation across the intestinal epithelium, we tested the 10ΔsadP1 and 10Δcps2ΔsadP1 mutants and their parental strains for their translocation capacity across polarized Caco-2 cells [6]. We observed a significant difference in translocation between strains with and without SadP1, in particular between unencapsulated mutant 10Δcps2 and its isogenic 10Δcps2ΔsadP1 mutant (2.3-fold, p<0.001) (Fig 7).

thumbnail
Fig 7. SadP1 contributes to the translocation of S. suis SS2/CC1 across human IEC.

Comparison of bacterial translocation efficiency of ΔsadP1 mutant strains and their encapsulated and unencapsulated (WT 10 and 10Δcps2) parental strains across differentiated human IEC (Caco-2). Unpaired Student's t-tests were used to test significant different translocation percentages compared to the parental strains (***, p< 0.001; **, p< 0.01; *, p< 0.05).

https://doi.org/10.1371/journal.pone.0175639.g007

Discussion

Similar to other streptococcal surface proteins involved in a wide range of physiological functions [42], SadP represents a bifunctional protein with host-cell adhesion and host immune evasion properties [4346]. The C-terminal domain of SadP was reported to bind to human complement factor H (Fhb), which is a glycoprotein that regulates the complement activation [43]. The galabiose-binding N-terminal domain of SadP showed high-affinity and specific binding to the Gb3/CD77 host-cell receptor [11, 47].

Transcript levels of SadP were highly up-regulated compared to transcript levels of other virulence factors in zoonotic and non-zoonotic isolates when interacting with human and porcine IEC, although SadP transcript levels varied between strains. Thus, we hypothesized that SadP is involved in the interaction with host IEC. We identified five main SadP genetic variants among 116 zoonotic and non-zoonotic isolates, which clustered according to genotype. We focused on a comparison of three SadP variants present in the most virulent genotypes circulating in the Netherlands: CC1, CC16 and CC20. In particular, SadP1 was associated to zoonotic and virulent isolates with CC1 genetic background.

We observed differences in the ability of SadP to adhere to IEC between S. suis strains carrying different SadP variants. The SadP1 deletion mutant of SS2/CC1 encapsulated strain 10 showed significantly lower adhesion to human as well as to porcine IEC than the parent strain. Previously it has been demonstrated that the expression of the cps could change in response to environmental stimuli in vivo [21, 48] and the presence or thickness of the capsule affected the bacterial interaction with the host-cells [6, 10]. Therefore, we studied the effect of SadP1 on IEC adhesion in SS2/CC1 10 strain unencapsulated mutant (10Δcps2), in which bacterial adhesins could have better access to bind specific host-cell receptors. The double 10Δcps2ΔsadP1 mutant still showed a significant reduction in adhesion to human IEC compared to its parental mutant but did not show a significant reduction in binding to porcine IEC. These results suggest that SadP1 strongly promotes the bacterial adhesion to the human intestinal epithelium independent of CPS expression, and contributes to the zoonotic potential of SS2/CC1 strains that mostly carry the SadP1 variant. Although the complemented SadP1 failed the full restoration of adhesion activity of the wild-type phenotype, its adhesion capacity with human IEC was significantly increased compared to the deletion mutant ΔsadP1. The somewhat lower adhesion of the complemented SadP1 may have been due to a low sadP1 gene expression or due to a suboptimal folding and assembly of SadP1 protein on the bacterial cell wall in our complementation system thus interfering with a correct docking of the SadP adhesin onto the galabiose moiety of the Gb3/CD77 receptor.

Interestingly, both encapsulated and unencapsulated SadP1 mutants were also impaired in their translocation across human IEC, supporting the hypothesis that direct adhesion and interaction of bacteria with specific host-cell receptors, potentially leading to the opening of the cellular tight junctions, is required for bacterial translocation [16]. Thus, we postulate that SadP1 contributes to colonization of human intestinal epithelium and hence permits S. suis translocation across the intestinal mucosa after adhesion. However, SadP1 deletion does not entirely abolish the bacterial adhesion capacity, similar to observations from other investigators when studying S. suis Fhb-mediated adhesion to epithelial and endothelial cells originating from other organ systems [45], indicating that other bacterial surface-associated factors are also likely to contribute to the adhesion of S. suis [16].

SadP1 and SadP2 notably differ in AA composition (77% similarity), while SadP2A and SadP2B share 99% similarity and differ only for the lack of LPXTG cell-anchor motif in SadP2B. The lack of this motif might suggest that SadP2B will be secreted instead of being anchored to the cell wall. We have previously shown that the zoonotic SS2/CC20 clone emerged from the non-zoonotic SS9/CC16 clone and the sequence similarity (99%) of the SadP2 variants present in CC20 and CC16 isolates is consistent with this observation [23]. While deletion of sadP2B in an SS9/CC16 strain resulted in a reduction of adhesion to porcine IEC, deletion of sadP2A in an SS2/CC20 strain had no effect on adhesion to both human and pig IEC. However, complementation with SadP2A, but not with SadP2B, restored the adhesion capacity to human (p< 0.05) and particularly to porcine IEC (p< 0.01) of ΔsadP1 in a SS2/CC1 strain. Thus, in the SS2/CC20 strain, other factors than SadP may contribute to adhesion masking the effect of SadP2A deletion, while the LPXTG cell-anchor motif present in SadP2A, but absent in SadP2B, might be a prerequisite for SadP mediated adhesion of CC1 to porcine IEC.

These results suggest that SadP2 variant is involved in the adhesion of IEC, but with a different degree of “host-specificity’ than SadP1, since it seems to mediate a major effect in the binding with porcine IEC.

We demonstrated that SadP1 contributes to the adhesion to human IEC by binding of Gb3/CD77 confirming previous functional studies on recombinant galabiose-binding N-terminal domain of SadP recognizing Gb3/CD77 as its natural glycolipid host-cell receptor [11, 47]. Recent studies on the structure of SadP1 in interaction with Gb2, which is analogous to Gb3/CD77, identified 10 AA critical for binding of SadP1 to the homologous structure of galabiose of Gb2 [47]. AA alignment of SadP1 and the two SadP2 variants revealed three relevant AA substitutions (Gly233→Ala233, Glu249→Gln249, Asn285→Asp285) in the binding pocket of the galabiose. These three AA are critical for the binding specificity with α-D-Gal of Gb2, and these substitutions might result in differences in binding affinity to different isoforms and forms of Gbs receptors among the SadP variants. This observation would be analogous to Stx variants, associated with different clinical outcomes of infections, which bind various isoforms and forms of Gbs receptors with different affinity as determined by variation in fatty acid composition [4952]. Similarly, differences in receptor recognition of Stx variants are known to mediate host-specificity [53, 54]. Gbs receptors, including Gb3/CD77 and Gb4, are widely expressed in tissues including human and porcine intestine [13, 14, 51]. Nevertheless, the distribution of these receptors varies between species, individuals and populations [12, 51]. With rare exceptions, erythrocytes of all individuals express different isoforms of Gbs receptors. Interestingly, erythrocytes with high Gb3/CD77 levels predominate (69–75%) in areas of Southeast Asia compared to other populations [12]. It is tempting to speculate that Southeast Asian population may be more susceptible to SS2/CC1 infection due to the high prevalence of the Gb3/CD77 receptor, which could, in addition to differences in exposure, partly explain the much higher S. suis disease incidence in South-East Asia [2].

Our findings contribute to a better understanding of specific host-pathogen interactions, showing that S. suis SadP1 contributes to the adhesion and translocation across host IEC. Different SadP variants might contribute to differences in host restriction between S. suis clones, due to differences in affinity and specificity of SadP-Gbs receptors interactions. Thus, components that interfere with bacterial binding to these receptors may have potential to reduce the burden of S. suis infection in both pigs and humans.

Supporting information

S1 File.

Fig A: Phylogenetic analysis of SadP variants including strains from Vietnam and the UK. The five identified SadP variants cluster together even when 375 strains from Weinert et al. [29] were included in the analysis, suggesting that the proposed five variants accurately describe the globally present SadP protein variants. The 111 strains used for determination of the variants are highlighted with colored blocks indicating to which clonal complex the strain belongs. Brackets indicate the different SadP variants. Fig B: Adhesion of S. suis ΔsadP2A and ΔsadP2B deletion mutants to human and porcine IEC. Percentage of adhesion of strain SS2/CC20 2001171 WT and its 2001171ΔsadP2A mutant; SS9/CC16 8067 WT strain and its isogenic mutant ΔsadP2B (8067ΔsadP2B) to human (Caco-2) and porcine (IPEC-J2) intestinal cells. Three independent experiments were performed in triplicate and the combined together. Unpaired Student's t-test was used to compare each ΔsadP2A and ΔsadP2B mutants with its own parental strains (***, p< 0.001; **, p< 0.01; *, p< 0.05). Table A: List of S. suis strains used in this study. Table B: List of primers used in this study.

https://doi.org/10.1371/journal.pone.0175639.s001

(DOCX)

Acknowledgments

We thank Prof. Takamatsu Daisuke (National Institute of Animal Health, NARO Japan) who kindly provided plasmid pMX1. The authors are grateful to Sander Keizer for his assistance with the complementation mutants and adhesion assays with IEC, and to Silvana Ross and Valerie van de Weijgert for their assistance with gene expression analysis.

Author Contributions

  1. Conceptualization: CS.
  2. Data curation: MLF NW.
  3. Formal analysis: MLF NW.
  4. Funding acquisition: CS.
  5. Investigation: MLF NW AE YP CS.
  6. Methodology: MLF NW EZ AE YP CS.
  7. Project administration: MLF NW CS.
  8. Resources: AE CS.
  9. Software: NW.
  10. Supervision: MLF AE YP CS.
  11. Validation: MLF NW AE YP CS.
  12. Visualization: MLF NW.
  13. Writing – original draft: MLF.
  14. Writing – review & editing: MLF NW EZ AE YP CS.

References

  1. 1. Wertheim HF, Nghia HD, Taylor W, Schultsz C. Streptococcus suis: an emerging human pathogen. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2009;48(5):617–25.
  2. 2. Goyette-Desjardins G, Auger JP, Xu J, Segura M, Gottschalk M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerging microbes & infections. 2014;3(6):e45. PubMed Central PMCID: PMC4078792.
  3. 3. de Greeff A, Wisselink HJ, de Bree FM, Schultsz C, Baums CG, Thi HN, et al. Genetic diversity of Streptococcus suis isolates as determined by comparative genome hybridization. BMC microbiology. 2011;11:161. PubMed Central PMCID: PMC3142484. pmid:21736719
  4. 4. Schultsz C, Jansen E, Keijzers W, Rothkamp A, Duim B, Wagenaar JA, et al. Differences in the population structure of invasive Streptococcus suis strains isolated from pigs and from humans in The Netherlands. PloS one. 2012;7(5):e33854. PubMed Central PMCID: PMC3341392. pmid:22563452
  5. 5. Kerdsin A, Hatrongjit R, Gottschalk M, Takeuchi D, Hamada S, Akeda Y, et al. Emergence of Streptococcus suis serotype 9 infection in humans. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2015.
  6. 6. Ferrando ML, de Greeff A, van Rooijen WJ, Stockhofe-Zurwieden N, Nielsen J, Wichgers Schreur PJ, et al. Host-pathogen interaction at the intestinal mucosa correlates with zoonotic potential of Streptococcus suis. The Journal of infectious diseases. 2014.
  7. 7. Nghia HD, Tu le TP, Wolbers M, Thai CQ, Hoang NV, Nga TV, et al. Risk factors of Streptococcus suis infection in Vietnam. A case-control study. PloS one. 2011;6(3):e17604. PubMed Central PMCID: PMC3050921. pmid:21408132
  8. 8. Takeuchi D, Kerdsin A, Pienpringam A, Loetthong P, Samerchea S, Luangsuk P, et al. Population-based study of Streptococcus suis infection in humans in Phayao Province in northern Thailand. PloS one. 2012;7(2):e31265. PubMed Central PMCID: PMC3283636. pmid:22363601
  9. 9. Wertheim HF, Nguyen HN, Taylor W, Lien TT, Ngo HT, Nguyen TQ, et al. Streptococcus suis, an important cause of adult bacterial meningitis in northern Vietnam. PloS one. 2009;4(6):e5973. PubMed Central PMCID: PMC2696092. pmid:19543404
  10. 10. Benga L, Goethe R, Rohde M, Valentin-Weigand P. Non-encapsulated strains reveal novel insights in invasion and survival of Streptococcus suis in epithelial cells. Cellular microbiology. 2004;6(9):867–81. pmid:15272867
  11. 11. Kouki A, Haataja S, Loimaranta V, Pulliainen AT, Nilsson UJ, Finne J. Identification of a novel streptococcal adhesin P (SadP) protein recognizing galactosyl-alpha1-4-galactose-containing glycoconjugates: convergent evolution of bacterial pathogens to binding of the same host receptor. The Journal of biological chemistry. 2011;286(45):38854–64. PubMed Central PMCID: PMC3234710. pmid:21908601
  12. 12. Cooling L. Blood Groups in Infection and Host Susceptibility. Clinical microbiology reviews. 2015;28(3):801–70. pmid:26085552
  13. 13. Winter KR, Stoffregen WC, Dean-Nystrom EA. Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes. Infection and immunity. 2004;72(11):6680–4. PubMed Central PMCID: PMC523021. pmid:15501802
  14. 14. Zumbrun SD, Hanson L, Sinclair JF, Freedy J, Melton-Celsa AR, Rodriguez-Canales J, et al. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide. Infection and immunity. 2010;78(11):4488–99. PubMed Central PMCID: PMC2976364. pmid:20732996
  15. 15. Devenica D, Cikes Culic V, Vuica A, Markotic A. Biochemical, pathological and oncological relevance of Gb3Cer receptor. Medical oncology. 2011;28 Suppl 1:S675–84.
  16. 16. Ferrando ML, Schultsz C. A hypothetical model of host-pathogen interaction of Streptococcus suis in the gastro-intestinal tract. Gut microbes. 2016:0.
  17. 17. Vriesema AJ, Brinkman R, Kok J, Dankert J, Zaat SA. Broad-host-range shuttle vectors for screening of regulated promoter activity in viridans group streptococci: isolation of a pH-regulated promoter. Applied and environmental microbiology. 2000;66(2):535–42. PubMed Central PMCID: PMC91860. pmid:10653715
  18. 18. Lievin-Le Moal V, Servin AL. Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines. Microbiology and molecular biology reviews: MMBR. 2013;77(3):380–439. PubMed Central PMCID: PMC3811612. pmid:24006470
  19. 19. Brosnahan AJ, Brown DR. Porcine IPEC-J2 intestinal epithelial cells in microbiological investigations. Veterinary microbiology. 2012;156(3–4):229–37. PubMed Central PMCID: PMC3289732. pmid:22074860
  20. 20. Sharma CM, Hoffmann S, Darfeuille F, Reignier J, Findeiss S, Sittka A, et al. The primary transcriptome of the major human pathogen Helicobacter pylori. Nature. 2010;464(7286):250–5. pmid:20164839
  21. 21. Ferrando ML, van Baarlen P, Orru G, Piga R, Bongers RS, Wels M, et al. Carbohydrate availability regulates virulence gene expression in Streptococcus suis. PloS one. 2014;9(3):e89334. PubMed Central PMCID: PMC3958366. pmid:24642967
  22. 22. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic acids research. 2009;37(6):e45. PubMed Central PMCID: PMC2665230. pmid:19237396
  23. 23. Willemse N, Howell KJ, Weinert LA, Heuvelink A, Pannekoek Y, Wagenaar JA, et al. An emerging zoonotic clone in the Netherlands provides clues to virulence and zoonotic potential of Streptococcus suis. Scientific reports. 2016;6:28984. PubMed Central PMCID: PMC4933891. pmid:27381348
  24. 24. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17(1):3.
  25. 25. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. Journal of computational biology: a journal of computational molecular cell biology. 2012;19(5):455–77. PubMed Central PMCID: PMC3342519.
  26. 26. Hyatt D, Chen GL, Locascio PF, Land ML, Larimer FW, Hauser LJ. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC bioinformatics. 2010;11:119. PubMed Central PMCID: PMC2848648. pmid:20211023
  27. 27. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic acids research. 2004;32(5):1792–7. PubMed Central PMCID: PMC390337. pmid:15034147
  28. 28. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Systematic biology. 2003;52(5):696–704. pmid:14530136
  29. 29. Weinert LA, Chaudhuri RR, Wang J, Peters SE, Corander J, Jombart T, et al. Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis. Nature communications. 2015;6:6740. PubMed Central PMCID: PMC4389249. pmid:25824154
  30. 30. Sung CK, Li H, Claverys JP, Morrison DA. An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae. Applied and environmental microbiology. 2001;67(11):5190–6. PubMed Central PMCID: PMC93289. pmid:11679344
  31. 31. Zaccaria E, van Baarlen P, de Greeff A, Morrison DA, Smith H, Wells JM. Control of competence for DNA transformation in Streptococcus suis by genetically transferable pherotypes. PloS one. 2014;9(6):e99394. PubMed Central PMCID: PMC4072589. pmid:24968201
  32. 32. Okura M, Osaki M, Fittipaldi N, Gottschalk M, Sekizaki T, Takamatsu D. The minor pilin subunit Sgp2 is necessary for assembly of the pilus encoded by the srtG cluster of Streptococcus suis. Journal of bacteriology. 2011;193(4):822–31. PubMed Central PMCID: PMC3028668. pmid:21148736
  33. 33. Esgleas M, Li Y, Hancock MA, Harel J, Dubreuil JD, Gottschalk M. Isolation and characterization of alpha-enolase, a novel fibronectin-binding protein from Streptococcus suis. Microbiology. 2008;154(Pt 9):2668–79. pmid:18757800
  34. 34. Ge J, Feng Y, Ji H, Zhang H, Zheng F, Wang C, et al. Inactivation of dipeptidyl peptidase IV attenuates the virulence of Streptococcus suis serotype 2 that causes streptococcal toxic shock syndrome. Current microbiology. 2009;59(3):248–55. pmid:19484301
  35. 35. Yuan ZZ, Yan XJ, Zhang AD, Chen B, Shen YQ, Jin ML. Molecular mechanism by which surface antigen HP0197 mediates host cell attachment in the pathogenic bacteria Streptococcus suis. The Journal of biological chemistry. 2013;288(2):956–63. PubMed Central PMCID: PMC3543045. pmid:23184929
  36. 36. Smith HE, Damman M, van der Velde J, Wagenaar F, Wisselink HJ, Stockhofe-Zurwieden N, et al. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infection and immunity. 1999;67(4):1750–6. PubMed Central PMCID: PMC96524. pmid:10085014
  37. 37. Wang Y, Gagnon CA, Savard C, Music N, Srednik M, Segura M, et al. Capsular sialic acid of Streptococcus suis serotype 2 binds to swine influenza virus and enhances bacterial interactions with virus-infected tracheal epithelial cells. Infect Immun. 2013;81(12):4498–508. PubMed Central PMCID: PMC3837972. pmid:24082069
  38. 38. Seitz M, Baums CG, Neis C, Benga L, Fulde M, Rohde M, et al. Subcytolytic effects of suilysin on interaction of Streptococcus suis with epithelial cells. Veterinary microbiology. 2013;167(3–4):584–91. pmid:24095145
  39. 39. Fontaine MC, Perez-Casal J, Willson PJ. Investigation of a novel DNase of Streptococcus suis serotype 2. Infect Immun. 2004;72(2):774–81. Epub 2004/01/27. pmid:14742520
  40. 40. Bonifait L, Grenier D. The SspA subtilisin-like protease of Streptococcus suis triggers a pro-inflammatory response in macrophages through a non-proteolytic mechanism. BMC Microbiol. 2011;11:47. Epub 2011/03/03. pmid:21362190
  41. 41. Zhang C, Yu Y, Yang M, Jiang Y. Expression, purification, crystallization and structure determination of the N terminal domain of Fhb, a factor H binding protein from Streptococcus suis. Biochemical and biophysical research communications. 2015;466(3):413–7. pmid:26365348
  42. 42. Bergmann S, Hammerschmidt S. Versatility of pneumococcal surface proteins. Microbiology. 2006;152(Pt 2):295–303. pmid:16436417
  43. 43. Pian Y, Gan S, Wang S, Guo J, Wang P, Zheng Y, et al. Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis. Infection and immunity. 2012;80(7):2402–13. PubMed Central PMCID: PMC3416472. pmid:22526676
  44. 44. Chen B, Zhang A, Li R, Mu X, He H, Chen H, et al. Evaluation of the protective efficacy of a newly identified immunogenic protein, HP0272, of Streptococcus suis. FEMS microbiology letters. 2010;307(1):12–8. pmid:20402782
  45. 45. Roy D, Grenier D, Segura M, Mathieu-Denoncourt A, Gottschalk M. Recruitment of Factor H to the Streptococcus suis Cell Surface is Multifactorial. Pathogens. 2016;5(3).
  46. 46. Ferrando ML, Fuentes S, de Greeff A, Smith H, Wells JM. ApuA, a multifunctional alpha-glucan-degrading enzyme of Streptococcus suis, mediates adhesion to porcine epithelium and mucus. Microbiology. 2010;156(Pt 9):2818–28. pmid:20522493
  47. 47. Zhang C, Hao H, Yu Y, Kong D, Chen S, Jiang H, et al. Structural basis of the interaction between the meningitis pathogen Streptococcus suis adhesin Fhb and its human receptor. FEBS letters. 2016;590(9):1384–92. pmid:27086582
  48. 48. Willenborg J, Fulde M, de Greeff A, Rohde M, Smith HE, Valentin-Weigand P, et al. Role of glucose and CcpA in capsule expression and virulence of Streptococcus suis. Microbiology. 2011;157(Pt 6):1823–33. Epub 2011/02/26. pmid:21349980
  49. 49. Sueoka H, Aoki M, Tsukimura T, Togawa T, Sakuraba H. Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an alpha-Galactosidase A Knockout Mouse, a Model of Fabry Disease. PloS one. 2015;10(12):e0144958. PubMed Central PMCID: PMC4685999. pmid:26661087
  50. 50. Kiarash A, Boyd B, Lingwood CA. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. The Journal of biological chemistry. 1994;269(15):11138–46. pmid:8157640
  51. 51. Waddell TE, Lingwood CA, Gyles CL. Interaction of verotoxin 2e with pig intestine. Infection and immunity. 1996;64(5):1714–9. PubMed Central PMCID: PMC173983. pmid:8613382
  52. 52. Muthing J, Schweppe CH, Karch H, Friedrich AW. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thrombosis and haemostasis. 2009;101(2):252–64. pmid:19190807
  53. 53. Karve SS, Weiss AA. Glycolipid binding preferences of Shiga toxin variants. PloS one. 2014;9(7):e101173. PubMed Central PMCID: PMC4077739. pmid:24983355
  54. 54. Ling H, Pannu NS, Boodhoo A, Armstrong GD, Clark CG, Brunton JL, et al. A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity. Structure. 2000;8(3):253–64. pmid:10745005